| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/11/1996 | WO1996021023A1 Dna sequences encoding carbohydrate polymer synthesizing enzymes and method for producing transgenic plants |
| 07/11/1996 | WO1996021022A2 Production of gamma linolenic acid by a δ6-desaturase |
| 07/11/1996 | WO1996021021A2 A cancer associated gene, testis-associated helicase (tah), protein expressed therefrom and uses thereof |
| 07/11/1996 | WO1996021017A2 Isolated dna encoding enzyme for phage resistance |
| 07/11/1996 | WO1996021016A2 New staphylokinase derivatives |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996021009A1 Method for generating proteolytic enzymes specific against a selected peptide sequence |
| 07/11/1996 | WO1996021008A1 Process for producing lignine-peroxydase and manganese-peroxydase from a culture of phanerochaete chrysosporium |
| 07/11/1996 | WO1996021005A1 Transgenic animals and related aspects |
| 07/11/1996 | WO1996020951A1 Chimeric dna-binding proteins |
| 07/11/1996 | WO1996020948A1 Human pak65 |
| 07/11/1996 | WO1996020945A1 Novel aminooligosaccharide derivative and process for preparing the same |
| 07/11/1996 | WO1996020721A1 Programmed cell death genes and proteins |
| 07/11/1996 | WO1996020717A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | WO1996020596A1 Use of flavonoid aldehydes as pesticides |
| 07/11/1996 | WO1996020595A1 Modulating toxic metabolite levels in consumable products |
| 07/11/1996 | WO1996013608A3 Polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms |
| 07/11/1996 | WO1996010635A3 Genes encoding signal recognition particle of aspergillus niger |
| 07/11/1996 | CA2209663A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | CA2209526A1 Programmed cell death genes and proteins |
| 07/11/1996 | CA2209226A1 Polymerase .delta. mutations in colorectal tumors with replication errors |
| 07/11/1996 | CA2209183A1 Chimeric dna-binding proteins |
| 07/11/1996 | CA2209082A1 Process for the production of ligine-peroxydase and of manganese-peroxydase from a phanerochaete chrysosporium culture |
| 07/11/1996 | CA2208755A1 Use of aromatic aldehydes as pesticides |
| 07/11/1996 | CA2208753A1 Modulating toxic metabolite levels in consumable products |
| 07/11/1996 | CA2208107A1 Isolated dna encoding enzyme for phage resistance |
| 07/11/1996 | CA2206479A1 New staphylokinase derivatives |
| 07/10/1996 | EP0721104A2 Preparation and stabilisation of cells |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720649A1 Novel xylanase, process for producing the same, method for the treatment of pulp, and production of xylo-oligosaccharides |
| 07/10/1996 | EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
| 07/10/1996 | EP0403506B1 Method of screening for protein inhibitors and activators |
| 07/10/1996 | CN1126493A Enzymatic preparation of monic acids |
| 07/10/1996 | CN1126490A Enhancement of laccase reactions |
| 07/10/1996 | CN1126487A Coated enzyme composition for washing and cleaning products |
| 07/10/1996 | CN1126477A Separation of proteins |
| 07/10/1996 | CN1126437A Preparation and stabilisation of cells |
| 07/10/1996 | CN1126423A Method of controlling insects |
| 07/10/1996 | CN1126243A Heat tolerant phytases |
| 07/10/1996 | CN1126207A Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
| 07/10/1996 | CN1032253C Process for preparation of oxalylamino acid derivatives, and their use as medicaments for inhibiting proline hydroxylase |
| 07/09/1996 | US5534529 Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 07/09/1996 | US5534432 Polyhydroxybutyrate polymerase |
| 07/09/1996 | US5534429 Strain of Cephalosporium having ATCC accession no. 74297, a process of isolating said strain of Cephalosporium and a process for preparing extracellular endoxylanase |
| 07/09/1996 | US5534428 Cloned Ssti/SacI restriction-modification system |
| 07/09/1996 | US5534427 Gene expression |
| 07/09/1996 | US5534426 Oncoprotein protein kinase |
| 07/09/1996 | US5534223 Immunoenzymological assay for proteins using alkaline phosphatase joined to polypeptides and interacting with antigens or antibodies |
| 07/09/1996 | CA2080971C Storable protein solution |
| 07/09/1996 | CA2050468C A thermostable (1,3-1,4)-.beta.-glucanase |
| 07/09/1996 | CA1338453C Purified protein having angiogenic activity and methods of preparation |
| 07/09/1996 | CA1338440C Process for the isolation and characterisation of a gene enzyme system for inactivation of the herbicide phenmedipham |
| 07/04/1996 | WO1996020403A1 Assay, receptor proteins and ligands |
| 07/04/1996 | WO1996020281A1 Human phosphodiesterase type ivc, and its production and use |
| 07/04/1996 | WO1996020280A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | WO1996020279A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | WO1996020275A1 PROCESS FOR PRODUCING D-N-CARBAMOYL-α-AMINO ACID |
| 07/04/1996 | WO1996020274A1 Enzyme stabilization |
| 07/04/1996 | WO1996020211A1 Phosphotyrosine assay and peptides for use therein |
| 07/04/1996 | WO1996020011A1 Chemical compounds |
| 07/04/1996 | WO1996019999A1 Thrombolytic enzyme and method of obtaining same |
| 07/04/1996 | WO1996011664A3 NSK2 a muscle receptor tyrosine kinase |
| 07/04/1996 | DE19521980C1 Transgenic animal deficient in acid sphingomyelinase |
| 07/04/1996 | CA2213122A1 Enzyme stabilization |
| 07/04/1996 | CA2208502A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | CA2208319A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2208318A1 Phosphotyrosine assay and peptides for use therein |
| 07/04/1996 | CA2208291A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | CA2205091A1 Chemical compounds |
| 07/04/1996 | CA2182946A1 Human phosphodiesterase type ivc, and its production and use |
| 07/03/1996 | EP0719862A2 A regulatory factor for expression of nitrilase gene and a gene thereof |
| 07/03/1996 | EP0719791A2 Medicaments for the treatment of restenosis and arterial sclerosis |
| 07/03/1996 | EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 07/03/1996 | EP0719560A1 Antibordetella acellular vaccine |
| 07/03/1996 | EP0719342A1 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
| 07/03/1996 | EP0719340A1 Cloned glutamic acid decarboxylase |
| 07/03/1996 | EP0719339A1 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 07/03/1996 | EP0719338A1 Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants and the modified starch obtainable therefrom |
| 07/03/1996 | EP0719337A1 PURIFIED pH NEUTRAL RHIZOCTONIA LACCASES AND NUCLEIC ACIDS ENCODING SAME |
| 07/03/1996 | EP0719334A1 Pharmaceutical compositions containing ecotin and homologs thereof |
| 07/03/1996 | EP0719327A1 Oxidation-stable proteases |
| 07/03/1996 | EP0719134A1 Skin care composition comprising thiol proteases from the stratum corneum |
| 07/03/1996 | EP0719133A1 Skin care method and composition |
| 07/03/1996 | EP0719132A1 Skin care method and composition |
| 07/03/1996 | EP0502976B1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 07/03/1996 | CN1125961A Process for the preparation of pyruvic acid |
| 07/02/1996 | US5532415 Monoamine oxidase inhibitors; parkinson's disease, nervous system disorders; cognition activators |
| 07/02/1996 | US5532220 Of mammarian cancer cells lacking endogeneous protein; introducing suppressor gene encoding protein into cells |
| 07/02/1996 | US5532161 Catalyzes removal of phthalyl group from phthalyl amides; hydrolysis catalyst |
| 07/02/1996 | US5532153 Method for cloning and producing the SacI restriction endonuclease |
| 07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
| 07/02/1996 | US5532151 Purified isolated polynucleotide encoding mammalian grk6 enzyme; dna vector; rna transcript of genomic dna; host cell stably transformed or transfected with the dna to allow expression in cell of grk6 enzyme with kinase activity; |
| 07/02/1996 | US5532149 Removal of phthalyl groups from amides and esters using an amidase isolated from Xanthobacter Agilis |
| 07/02/1996 | US5532142 Proteins for genetic engineering with dna using proteinase |
| 07/02/1996 | US5532124 Genetically engineered bacteria to identify and produce medically important agents |
| 07/02/1996 | US5532123 Receptor-type phosphotyrosine phosphatase-γ |
| 07/02/1996 | US5531918 Novel proteases |
| 06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 06/27/1996 | WO1996019583A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |